People

Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
NYU School of Global Public Health - Professor
Education
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
BIO
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Projects
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Active
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Active
Principal Investigator, Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed
Publications

Recent

Bradley H, Austin C, Allen ST, Asher A, Bartholomew TS, Board A, Borquez A, Buchacz K, Carter A, Cooper HLF, Feinberg J, Furukawa N, Genberg B, Gorbach PM, Hagan H, Huriaux E, Hurley H, Luisi N, Martin NK, Rosenberg ES, Strathdee SA, Des Jarlais DC (2022).
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic
International Journal of Drug Policy, 110, 103889. doi: 10.1016/j.drugpo.2022.103889. PMCID: PMC9574463.

Giang HT, Nguyen DQ, Moles JP, Vinh VH, Nagot N, Thanh NTT, Huong DT, Oanh KTH, Khue PM, Le SM, Nguyen T, Ngoc PT, Quillet C, Feelemyer J, Vallo R, Michel L, Des Jarlais D, Laureillard D, Rapoud D (2022).
Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam
International Journal of Drug Policy, 110, 103870. doi: 10.1016/j.drugpo.2022.103870. PMCID: PMC9489978.

Wiessing L, Sypsa V, Abagiu AO, ... Feelemyer J, ...Hatzakis A..., Des Jarlais D (2022).
Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel
AIDS and Behavior [Epub 2022 Nov 11]. doi: 10.1007/s10461-022-03851-x.

Des Jarlais DC, Behrends CN, Corcorran MA, Glick SN, Perlman DC, Kapadia SN, Lu X, Feelemyer J, LaKosky P, Prohaska SM, Schackman BR (2022).
Availability of and obstacles to providing COVID-19 vaccinations at syringe services programs in the United States, 2021
Public Health Reports, 137 (6), 1066-1069. doi: 10.1177/00333549221120241. PMCID: PMC9574299.

Austin EJ, Corcorran MA, Briggs ES, Frost MC, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN (2022).
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives Copy
International Journal of Drug Policy, 109, 103825. doi: 10.1016/j.drugpo.2022.103825. PMCID: PMC9364718.


Notable

Des Jarlais DC, Huong DT (2018).
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.

Dr. Des Jarlais' ResearchGate Profile
Selected Press